Patients with APS have chronically elevated levels of aPL, with higher levels of aPL and triple-positivity for aCL, anti- β2GPI and lupus anticoagulant both being associated with higher risk of thrombosis (25). The gene discussed is ACLY; the disease is autoimmune polyendocrinopathy.